Transmission of Multi-Drug Resistant HIV-1 Despite Antiretroviral Prophylaxis

被引：0
|
作者：
Soriano, Vicente [1 ]
机构：
[1] Autonomous Univ Madrid, La Paz Univ Hosp, Madrid, Spain
来源：
AIDS REVIEWS | 2017年 / 19卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [21] A multi-drug resistant HIV-1 protease is resistant to the dimerization inhibitory activity of TLF-PafF
    [J]. Kovari, Ladislau C, 1600, Elsevier Inc. (53):
  • [22] Multi-drug resistant tuberculosis in HIV
    Okelo, G. B. A.
    [J]. DISCOVERY AND INNOVATION, 2005, 17 : 38 - 39
  • [23] Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir
    Wensing, Annemarie M. J.
    Boucher, Charles A. B.
    van Kasteren, Marjo
    van Dijken, Pieter J.
    Geelen, Sybil P.
    Juttmann, Job R.
    [J]. AIDS, 2006, 20 (10) : 1465 - 1467
  • [24] Newly Acquired HIV-1 Infection with Multi-Drug Resistant (MDR) HIV-1 in a Patient on TDF/FTC-based PrEP
    Grossman, Howard
    Anderson, Peter
    Grant, Robert
    Gandhi, Monica
    Mohri, Hiroshi
    Markowitz, Martin
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 44 - 44
  • [25] Crystallographic study of multi-drug resistant HIV-1 protease lopinavir complex: Mechanism of drug recognition and resistance
    Liu, Zhigang
    Yedidi, Ravikiran S.
    Wang, Yong
    Dewdney, Tamaria G.
    Reiter, Samuel J.
    Brunzelle, Joseph S.
    Kovari, Iulia A.
    Kovari, Ladislau C.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 437 (02) : 199 - 204
  • [26] Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission
    Kumwenda, Newton I.
    Hoover, Donald R.
    Mofenson, Lynne M.
    Thigpen, Michael C.
    Kafulafula, George
    Li, Qing
    Mipando, Linda
    Nkanaunena, Kondwani
    Mebrahtu, Tsedal
    Bulterys, Marc
    Fowler, Mary Glenn
    Taha, Taha E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (02): : 119 - 129
  • [27] Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission - Reply
    Kuhn, Louise
    Sinkala, Moses
    Aldrovandi, Grace
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17): : 1847 - 1848
  • [28] Long-acting lenacapavir in people with multi-drug resistant HIV-1: week 52 results
    Ogbuagu, Onyema
    Segal-Maurer, Sorana
    Brinson, Cynthia
    Chetchotisakd, Ploenchan
    McGowan, Joseph P.
    Workowski, Kimberly
    Wang, Hui
    Margot, Nicolas
    Dvory-Sobol, Hadas
    Rhee, Martin S.
    Baeten, Jared
    Kabagambe, Samm
    Molina, Jean-Michel
    [J]. HIV MEDICINE, 2022, 23 : 26 - 27
  • [29] Unique response of tipranavir to multi-drug resistant HIV-1 proteases suggests new ways of combating drug resistance
    Muzammil, S
    Kong, LW
    Armstrong, AA
    Jakalian, A
    Bonneau, PR
    Schmelmer, V
    Amzel, LM
    Freire, E
    [J]. ANTIVIRAL THERAPY, 2005, 10 (04) : S70 - S70
  • [30] Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen
    Beltrami, EM
    Luo, CC
    de la Torre, N
    Cardo, DM
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (06): : 345 - 348
12345